Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-11-30
1985-10-15
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 90, 546144, A61K 31445, C07D40104
Patent
active
045475083
ABSTRACT:
1-Phenylisoquinoline derivatives of the general formula I ##STR1## and a process for their preparation are described. They act on the central nervous system, in particular as antidepressants.
REFERENCES:
patent: 3457265 (1969-07-01), Seeger et al.
patent: 3544577 (1970-12-01), Seeger et al.
patent: 3891654 (1975-06-01), Valette
patent: 4386090 (1983-05-01), Moinet et al.
patent: 4431851 (1984-02-01), Moinet et al.
10 Eur. J. Med. Chem. 603 (1975).
Synthesis 281 (1979).
Liebigs Ann. Chem. 1978 (1963).
21 J. Med. Chem. 309 (1978).
12 J. Med. Chem. 851-54 (1969).
2 Handbook of Neurochemistry, 327-64 (1969).
23 Biochemical Pharmac. 3413-22 (1974).
Pictet et al., "Chem. Ber.", vol. 42, 1909, pp. 1973-1989.
Spath et al., "Chem. Ber.", vol. 63, 1930, pp. 134-141.
Grierson et al., "J. Amer. Chem. Soc.", vol. 102(3), 1980, pp. 1064-1081.
Miller et al., "J. Amer. Chem. Soc.", vol. 78, 1956, pp. 674-676.
Wright et al., "J. Org. Chem.", vol. 26, 1961, pp. 4057-4060.
Konz Elmar
Kruse Hansjorg
Hoechst Aktiengesellschaft
Raymond Richard L.
Turnipseed James H.
LandOfFree
1-Phenylisoquinoline derivatives, pharmaceutical products contai does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Phenylisoquinoline derivatives, pharmaceutical products contai, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Phenylisoquinoline derivatives, pharmaceutical products contai will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2431734